期刊
CLINICAL LYMPHOMA
卷 3, 期 4, 页码 257-259出版社
CANCER INFORMATION GROUP, LP
DOI: 10.3816/CLM.2003.n.008
关键词
B cells; CD80; immunotherapy; non-Hodgkin's lymphoma; Primatized (R); rituximab